1. Home
  2. APT vs BTAI Comparison

APT vs BTAI Comparison

Compare APT & BTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Pro Tech Ltd.

APT

Alpha Pro Tech Ltd.

N/A

Current Price

$4.53

Market Cap

50.4M

Sector

N/A

ML Signal

N/A

Logo BioXcel Therapeutics Inc.

BTAI

BioXcel Therapeutics Inc.

HOLD

Current Price

$1.87

Market Cap

49.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APT
BTAI
Founded
1983
2017
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.4M
49.2M
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
APT
BTAI
Price
$4.53
$1.87
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$32.80
AVG Volume (30 Days)
26.1K
578.0K
Earning Date
11-05-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.34
N/A
Revenue
$59,096,000.00
$752,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$416.40
P/E Ratio
$13.53
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.06
$1.17
52 Week High
$6.20
$9.26

Technical Indicators

Market Signals
Indicator
APT
BTAI
Relative Strength Index (RSI) 47.82 43.92
Support Level $4.49 $1.82
Resistance Level $4.68 $2.30
Average True Range (ATR) 0.14 0.17
MACD 0.01 0.01
Stochastic Oscillator 35.45 11.80

Price Performance

Historical Comparison
APT
BTAI

About APT Alpha Pro Tech Ltd.

Alpha Pro Tech Ltd is in the business of protecting people, products and environments. It is developing, manufacturing and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical and dental markets. It also manufacture a line of building supply construction weatherization products that are sold under the Alpha Pro Tech brand name. The Company operates through two business segments: Building Supply and Disposable Protective Apparel. Key revenue is generated from Building Supply: consisting of a line of construction supply weatherization products. The construction supply weatherization products consist of housewrap and synthetic roof underlayment and synthetic roof underlayment accessories.

About BTAI BioXcel Therapeutics Inc.

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.

Share on Social Networks: